Adherium’s CEO to present at 2022 ANDHealth Digital Health Summit
Melbourne, Australia – 18 May 2022: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce its CEO, Rick Legleiter, was selected to present in the Challenges for DTx Companies in Australia session of ANDHealth Digital Health Summit 2022 in Melbourne on May 24th from 3:15pm to 4:00pm.
ANDHealth has led the dialogue on digital health commercialisation across Australia through their Summits and Programs since 2017. This year’s event marks the return of their in-person highly regarded Digital Health Summit Series kicking off with the AusMedtech satellite event. The topic for discussion this year is Technology as Therapy: How Digital Medicine & Digital Therapeutics are Transforming Healthcare.
Adherium’s Chief Executive Officer, Rick Legleiter, commented: “I am delighted to be one of the selected panellists at 2022 ANDHealth Digital Health Summit to facilitate a greater understanding of this new and emerging space in Australia and to share industry experience and learnings.”
Digital therapeutics (DTx) is set to be the next healthcare wave and is rapidly transforming the way patients access health data via innovative products, such as Adherium’s technology, the Hailie® solution, which monitors inhaled medication adherence supporting the reduction in frequency of exacerbations and the associated hospital admissions, improving outcomes and quality of life.
ANDHealth Digital Health Summit is a limited event with 80 places available for registered attendees. The event will also be live streamed to a larger virtual audience comprising of business leaders, entrepreneurs, investors, clinicians, researchers, product developers and industry experts on digital health tech. Please click here to register your attendance.
